2-Chloro-5-fluorobenzoic acid | CAS:2252-50-8

We serve 2-Chloro-5-fluorobenzoic acid CAS:2252-50-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Chloro-5-fluorobenzoic acid

Chemical Name:2-Chloro-5-fluorobenzoic acid
CAS.NO:2252-50-8
Synonyms:2-Chloro-5-fluorobenzoic acid
5-fluoro-2-chlorobenzoic acid
2-Chloro-5-fluorobenzoicacid
2-Chlor-5-fluor-benzoesaeure
Molecular Formula:C7H4ClFO2
Molecular Weight:174.55700
 
Physical and Chemical Properties:
Density:1.477
Melting point:147-149ºC
Boiling point:275.3ºC
Flash point:120.3ºC
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-Chloro-5-fluorobenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chlor-5-fluor-benzoesaeure physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-fluoro-2-chlorobenzoic acid Use and application,2-Chloro-5-fluorobenzoicacid technical grade,usp/ep/jp grade.


Related News: Airlines operating in the United States will be required to ask all passengers booked on flights from outside the US if they’ve been to mainland China in last 14 days.(2S)-propane-1,2-diamine,dihydrochloride manufacturer Airlines operating in the United States will be required to ask all passengers booked on flights from outside the US if they’ve been to mainland China in last 14 days.2,5-Dibromopyridine supplier International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.Methyl 3-chlorosulfonylthiophene-2-carboxylate vendor International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.There’s still a lot we don’t know about the coronavirus, and scientists internationally are racing to gather data and develop a treatment.